3,4-methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans:: Psychomotor performance, subjective effects, and pharmacokinetics

被引:110
作者
Hernández-López, C
Farré, M
Roset, PN
Menoyo, E
Pizarro, N
Ortuño, J
Torrens, M
Camí, J
De la Torre, R
机构
[1] Inst Municipal Invest Med, Pharmacol Unit, E-08003 Barcelona, Spain
[2] Univ Autonoma Barcelona, E-08193 Barcelona, Spain
[3] Hosp Mar, Unit Psychiat, Barcelona, Spain
[4] Univ Pompeu Fabra, Barcelona, Spain
关键词
D O I
10.1124/jpet.300.1.236
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
3,4-Methylenedioxymethamphetamine (MDMA) is frequently consumed in association with alcohol. The effect of this combination in humans has not been previously investigated. Nine male healthy volunteers received single oral doses of 100 mg of MDMA plus 0.8 g/kg ethanol, 100 mg of MDMA, 0.8 g/kg of ethanol, and placebo in a double blind, double dummy, randomized crossover trial. Measurements included psychomotor performance, subjective effects, and pharmacokinetics. Plasma concentrations of MDMA showed a 13% increase after the use of alcohol, whereas plasma concentrations of alcohol showed a 9 to 15% decrease after MDMA administration. The MDMA-alcohol combination induced longer lasting euphoria and well being than MDMA or alcohol alone. MDMA reversed the subjective sedation induced by alcohol but did not reduce drunkenness feelings. MDMA did not reverse the actions of alcohol on psychomotor abilities. Combined use of MDMA and alcohol causes dissociation between subjective and objective sedation. Subjects may feel euphoric and less sedated and might have the feeling of doing better, but actual performance ability continues to be impaired by the effect of alcohol. Confirmation of these findings in further studies will be highly relevant in terms of road safety.
引用
收藏
页码:236 / 244
页数:9
相关论文
共 39 条
[1]   Response patterns of the Spanish version of the 49-item short form of the Addiction Research Center Inventory after the use of sedatives, stimulants, and opioids [J].
Arasteh, K ;
Poudevida, S ;
Farré, M ;
Roset, PN ;
Camí, J .
DRUG AND ALCOHOL DEPENDENCE, 1999, 55 (1-2) :117-125
[2]   METHYLENEDIOXYMETHAMPHETAMINES CAPACITY TO ESTABLISH PLACE PREFERENCES AND MODIFY INTAKE OF AN ALCOHOLIC BEVERAGE [J].
BILSKY, EJ ;
HUI, YZ ;
HUBBELL, CL ;
REID, LD .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 37 (04) :633-638
[3]   Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"):: Psychomotor performance and subjective effects [J].
Camí, J ;
Farré, M ;
Mas, M ;
Roset, PN ;
Poudevida, S ;
Mas, A ;
San, L ;
de la Torre, R .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (04) :455-466
[4]  
CAMI J, 2000, NAT I DRUG ABUSE RES, V180
[5]   THE PSYCHOLOGICAL AND PHYSIOLOGICAL-EFFECTS OF MDMA ON NORMAL VOLUNTEERS [J].
DOWNING, J .
JOURNAL OF PSYCHOACTIVE DRUGS, 1986, 18 (04) :335-340
[6]   Effects of moderate alcohol consumption on the central nervous system [J].
Eckardt, MJ ;
File, SE ;
Gessa, GL ;
Grant, KA ;
Guerri, C ;
Hoffman, PL ;
Kalant, H ;
Koob, GF ;
Li, TK ;
Tabakoff, B .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1998, 22 (05) :998-1040
[7]   A comparison of the acute behavioral effects of flunitrazepam and triazolam in healthy volunteers [J].
Farre, M ;
Teran, MT ;
Cami, J .
PSYCHOPHARMACOLOGY, 1996, 125 (01) :1-12
[8]  
FARRE M, 1993, J PHARMACOL EXP THER, V266, P1364
[9]  
Farre M, 1997, J PHARMACOL EXP THER, V283, P164
[10]  
GAMELLA JF, 1997, P 7 ANN C DRUG US DR, P130